Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/31875
Type
ArticleCopyright
Restricted access
Embargo date
2021-12-31
Collections
- INI - Artigos de Periódicos [3541]
Metadata
Show full item record
EFFECTS OF ORGANIZATIONAL CHARACTERISTICS ON OUTCOMES AND RESOURCE USE IN PATIENTS WITH CANCER ADMITTED TO INTENSIVE CARE UNITS
Author
Soares, Marcio
Bozza, Fernando A.
Azevedo, Luciano C. P.
Silva, Ulysses V. A.
Corrêa, Thiago D.
Colombari, Fernando
Torelly, André P.
Varaschin, Pedro
Viana, William N.
Knibel, Marcos F.
Damasceno, Moyzés
Espinoza, Rodolfo
Ferez, Marcus
Silveira, Juliana G.
Lobo, Suzana A.
Moraes, Ana Paula P.
Lima, Ricardo A.
Carvalho, Alexandre G. R. de
Brasil, Pedro Emmanuel Alvarenga Americano do
Kahn, Jeremy M.
Angus, Derek C.
Salluh, Jorge I. F.
Bozza, Fernando A.
Azevedo, Luciano C. P.
Silva, Ulysses V. A.
Corrêa, Thiago D.
Colombari, Fernando
Torelly, André P.
Varaschin, Pedro
Viana, William N.
Knibel, Marcos F.
Damasceno, Moyzés
Espinoza, Rodolfo
Ferez, Marcus
Silveira, Juliana G.
Lobo, Suzana A.
Moraes, Ana Paula P.
Lima, Ricardo A.
Carvalho, Alexandre G. R. de
Brasil, Pedro Emmanuel Alvarenga Americano do
Kahn, Jeremy M.
Angus, Derek C.
Salluh, Jorge I. F.
Affilliation
D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil.
D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil / Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Hospital Sírio-Libanês. São Paulo, SP, Brasil.
Fundação Pio XII. Hospital de Câncer de Barretos. Barretos, SP, Brasil.
Hospital Israelita Albert Einstein. São Paulo, SP, Brasil.
Hospital Alemão Oswaldo Cruz. São Paulo, SP, Brasil.
Santa Casa de Misericórdia de Porto Alegre. Complexo Hospitalar. Porto Alegre, RS, Brasil.
Hospital Pasteur. Rio de Janeiro, RJ, Brasil.
Hospital Copa D’Or. Rio de Janeiro, RJ, Brasil.
Hospital São Lucas. Rio de Janeiro, RJ, Brasil.
Complexo Hospitalar de Niterói. Niterói, RJ, Brasil.
Instituto Nacional de Câncer. Hospital do Câncer II. Rio de Janeiro, RJ, Brasil.
Hospital São Francisco. Ribeirão Preto, SP, Brasil.
Hospital Quinta D’Or. Rio de Janeiro, RJ, Brasil.
Hospital de Base de São José do Rio Preto. São José do Rio Preto, SP, Brasil.
Hospital de Câncer do Maranhão Dr. Tarquínio Lopes Filho. São Luís, MA, Brasil.
Hospital Samaritano. Rio de Janeiro, RJ, Brasil.
UDI Hospital. São Luís, MA, Brasil.
D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil / Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
University of Pittsburgh. Graduate School of Public Health. Pittsburgh, PA, USA / University of Pittsburgh. School of Medicine. Pittsburgh, PA, USA.
University of Pittsburgh. School of Medicine. Pittsburgh, PA, USA.
D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil.
D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil / Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Hospital Sírio-Libanês. São Paulo, SP, Brasil.
Fundação Pio XII. Hospital de Câncer de Barretos. Barretos, SP, Brasil.
Hospital Israelita Albert Einstein. São Paulo, SP, Brasil.
Hospital Alemão Oswaldo Cruz. São Paulo, SP, Brasil.
Santa Casa de Misericórdia de Porto Alegre. Complexo Hospitalar. Porto Alegre, RS, Brasil.
Hospital Pasteur. Rio de Janeiro, RJ, Brasil.
Hospital Copa D’Or. Rio de Janeiro, RJ, Brasil.
Hospital São Lucas. Rio de Janeiro, RJ, Brasil.
Complexo Hospitalar de Niterói. Niterói, RJ, Brasil.
Instituto Nacional de Câncer. Hospital do Câncer II. Rio de Janeiro, RJ, Brasil.
Hospital São Francisco. Ribeirão Preto, SP, Brasil.
Hospital Quinta D’Or. Rio de Janeiro, RJ, Brasil.
Hospital de Base de São José do Rio Preto. São José do Rio Preto, SP, Brasil.
Hospital de Câncer do Maranhão Dr. Tarquínio Lopes Filho. São Luís, MA, Brasil.
Hospital Samaritano. Rio de Janeiro, RJ, Brasil.
UDI Hospital. São Luís, MA, Brasil.
D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil / Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
University of Pittsburgh. Graduate School of Public Health. Pittsburgh, PA, USA / University of Pittsburgh. School of Medicine. Pittsburgh, PA, USA.
University of Pittsburgh. School of Medicine. Pittsburgh, PA, USA.
D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil.
Abstract
Purpose: To investigate the impact of organizational characteristics and processes of care on hospital mortality and resource use in patients with cancer admitted to intensive care units (ICUs). Patients and Methods. We performed a retrospective cohort study of 9,946 patients with cancer (solid, n = 8,956; hematologic, n = 990) admitted to 70 ICUs (51 located in general hospitals and 19 in cancer centers) during 2013. We retrieved patients’ clinical and outcome data from an electronic ICU quality registry. We surveyed ICUs regarding structure, organization, staffing patterns, and processes of care. We used mixed multivariable logistic regression analysis to identify characteristics associated with hospital mortality and efficient resource use in the ICU. Results: Median number of patients with cancer per center was 110 (interquartile range, 58 to 154), corresponding to 17.9% of all ICU admissions. ICU and hospital mortality rates were 15.9% and 25.4%, respectively. After adjusting for relevant patient characteristics, presence of clinical pharmacists in the ICU (odds ratio [OR], 0.67; 95% CI, 0.49 to 0.90), number of protocols (OR, 0.92; 95% CI, 0.87 to 0.98), and daily meetings between oncologists and intensivists for care planning (OR, 0.69; 95% CI, 0.52 to 0.91) were associated with lower mortality. Implementation of protocols (OR, 1.52; 95% CI, 1.11 to 2.07) and meetings between oncologists and intensivists (OR, 4.70; 95% CI, 1.15 to 19.22) were also independently associated with more efficient resource use. Neither admission to ICUs in cancer centers compared with general hospitals nor annual case volume had an impact on mortality or resource use. Conclusion: Organizational aspects, namely the implementation of protocols and presence of clinical pharmacists in the ICU, and close collaboration between oncologists and ICU teams are targets to improve mortality and resource use in critically ill patients with cancer.
Share